Overview
- 14 inspections across 13 sites are on record.
- 49 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-07-13.
At a glance
Inspections
14
Sites
13
Observations
49
Career since
May 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Medical Products Laboratories, Inc. | 13 Jul 2023 | Human Drugs | View 483 → |
| Bostal LLC | 5 Apr 2023 | Human Drugs | View 483 → |
| I 3 PHARMACEUTICALS, LLC | 3 Mar 2023 | Human Drugs | On file |
| Akina Pharmacy | 9 Dec 2022 | Human Drugs | View 483 → |
| New Dawn Manufacturing | 29 Aug 2022 | Human Drugs |
Sites inspected
Medical Products Laboratories, Inc.Philadelphia, United States1 insp.
Bostal LLCEdison, United States1 insp.
I 3 PHARMACEUTICALS, LLCWarminster, United States1 insp.
Akina PharmacySterling, United States1 insp.
New Dawn ManufacturingUpper Marlboro, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
David A Oluwo4 shared
Janet A Rajan2 shared
Marcellinus D Dordunoo2 shared
Frederick Razzaghi2 shared
Amit Kokate1 shared
Elaine E Gilfillan1 shared
Amy N Chen1 shared
Natasha Gupta1 shared
Sayyem H Akbar1 shared
Jonathan G Matrisciano1 shared
Full investigator report
Get the verbatim findings behind Daniel J Min's 49 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site